Cyclin D1 expression in B-cell lymphomas

Experimental Hematology

Volumn 38, Issue 11, 2010, Pages 1047-1057

  Gladkikh, Aleena ^a   Potashnikova, Daria ^a   Korneva, Elena ^a   Khudoleeva, Olga ^a   Vorobjev, Ivan ^a  

^a NATIONAL RESEARCH CENTER FOR HEMATOLOGY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; CYCLIN D1; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; PROTEIN YWHAZ; UBIQUITIN C; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; CARCINOGENESIS; CHROMOSOME TRANSLOCATION 11; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; FOLLICULAR LYMPHOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; LARGE CELL LYMPHOMA; LYMPH NODE BIOPSY; LYMPHOID TISSUE; MAJOR CLINICAL STUDY; MANTLE CELL LYMPHOMA; MARGINAL ZONE LYMPHOMA; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN BIOPSY;

AGED; B-LYMPHOCYTES; CYCLIN D1; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LEUKOCYTES, MONONUCLEAR; LYMPH NODES; LYMPHOMA, B-CELL; LYMPHOMA, B-CELL, MARGINAL ZONE; LYMPHOMA, FOLLICULAR; LYMPHOMA, LARGE B-CELL, DIFFUSE; LYMPHOMA, MANTLE-CELL; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPLEEN;

EID: 78649368527     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2010.08.002     Document Type: Article

References (35)

1. Raffeld M., Jaffe E.S. Bcl-1, t(11;14), and mantle cell -derived lymphomas. Blood 1991, 78:259-263.
2. Weisenburger D.D., Armitage J.O. Mantle cell lymphoma -an entity comes of age. Blood 1996, 87:4483-4494.
3. Jares P., Campo E. Advances in the understanding of mantle cell lymphoma. Br J Haematol 2008, 142:149-165.
4. Sherr C.J. G1 phase progression: cycling on cue. Cell 1994, 79:551-555.
5. Rosenberg C.L., Wong E., Petty E.M., et al. PRAD 1, a candidate BCL1 oncogene: mapping and expression in centrocytic lymphoma. Proc Natl Acad Sci U S A 1991, 88:9638-9642.
6. Tanguay D.A., Chiles T.C. Regulation of the catalytic subunit (p34PSK-J3/cdk4) for the major D-type cyclin in mature B lymphocytes. J Immunol 1996, 156:539-548.
7. Solvason N., Wu W.W., Kabra N., Wu X., Lees E., Howard M.C. Induction of cell cycle regulatory proteins in anti-immunoglobulin-stimulated mature B lymphocytes. J Exp Med 1996, 184:407-417.
8. Ajchenbaum F., Ando K., DeCaprio J.A., Griffin J.D. Independent regulation of human D-type cyclin gene expression during G1 phase in primary human T lymphocytes. J Biol Chem 1993, 268:4113-4119.
9. Soverini S., Cavo M., Cellini C., et al. Cyclin D1 overexpression is a favourable prognostic variable for newly diagnosed multiple myeloma patients treated with high-dose chemotherapy and single or double autologous transplantation. Blood 2003, 102:1588-1594.
10. Sauerbrey A., Haefer R., Zintl F., Volm M. Analysis of cyclin D1 in de novo and relapsed childhood acute lymphoblastic leukemia. Anticancer Res 1999, 19:645-649.
11. Bosch F., Campo E., Jares P., et al. Increased expression of the PRAD-1/CCND1 gene in hairy cell leukaemia. Br J Haematol 1995, 91:1025-1030.
12. Ravandi-Cashani F., O'Brien S., Manshouri T., et al. Variations in the low levels of cyclin D1/BCL1 have prognostic value in chronic lymphocytic leukemia. Leuk Res 2000, 24:469-474.
13. Meyerson H.J., MacLennan G., Husel W., et al. D cyclins in CD5+ B-cell lymphoproliferative disorders: cyclin D1 and cyclin D2 identify diagnostic groups and cyclin D1 correlates with ZAP-70 expression in chronic lymphocytic leukemia. Am J Clin Pathol 2002, 125:241-250.
14. Jain P., Giustolisi G.M., Elnenaei M.O., et al. Detection of cyclin D1 in B-cell lymphoproliferative disorders by flow cytometry. J Clin Pathol 2002, 55:940-945.
15. Bijwaard K.E., Aguilera N.S., Monczak Y., Trudel M., Taubenberger J.K., Lichy J.H. Quantitative real-time reverse transcription-PCR assay for cyclin D1 expression: utility in the diagnosis of mantle cell lymphoma. Clin Chem 2001, 47:195-201.
16. Howe J.G., Crouch J., Cooper D., Smith B.R. Real-time quantitative reverse transcription-PCR for cyclin D1 mRNA in blood, marrow, and tissue specimens for diagnosis of mantle cell lymphoma. Clin Chem 2004, 50:80-87.
17. Specht K., Kremer M., Müller U., et al. Identification of cyclin D1 mRNA overexpression in B-cell neoplasias by real-time reverse transcription-PCR of microdissected paraffin sections. Clin Cancer Res 2002, 8:2902-2911.
18. Medeiros L.J., Hai S., Thomazy V.A., Estalilla O.C., Romaguera J., Luthra R. Real-time RT-PCR assay for quantifying cyclin D1 mRNA in B-cell non-Hodgkin's lymphomas. Mod Pathol 2002, 15:556-564.
19. Vandesompele J., De Preter K., Pattyn F., et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002, 3. RESEARCH0034.
20. Petrosyan K., Tamayo R., Joseph D. Sensitivity of a novel biotin-free detection reagent (Powervision+) for immunohistochemistry. J Histotechnol 2002, 25:247-250.
21. Gretsov E.M., Churakova J.V., Sheval E.V., Vorobjev I.A. Comparative characteristics of immunological, clinical and morphological features of human lymphoid tumors in respect with tumor genesis and progression. Russ J Dev Biol 2004, 35:182-190.
22. Pathology and Genetics of Haemo (World Health Organization Classification of Tumours S.) 2001, Oxford University Press, New York, ; pp. 119-185; ISBN 92-832-2411-6.
23. Bustin S.A. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol 2000, 25:169-193.
24. Lossos I.S., Czerwinski D.K., Wechser M.A., Levy R. Optimization of quantitative real-time RT-PCR parameters for the study of lymphoid malignancies. Leukemia 2003, 17:789-795.
25. -ΔΔCt method. Methods 2001, 25:402-408.
26. Polak J., Hradkova M., Schwarz J., et al. Expression of cyclins D1, D2, and D3 and Ki-67 in Leukemia. Leuk Lymphoma 2005, 46:1605-1612.
27. Chuang S.S., Huang W.T., Hsieh P.P., et al. Mantle cell lymphoma in Taiwan: clinicopathological and molecular study of 21 cases including one cyclin D1-negative tumor expressing cyclin D2. Pathol Int 2006, 56:440-448.
28. Kheirelseid E.A., Chang K.H., Newell J., Kerin M.J., Miller N. Identification of endogenous control genes for normalisation of real-time quantitative PCR data in colorectal cancer. BMC Mol Biol 2010, 11:12.
29. Fritzsche F.R., Wassermann K., Jung M. ADAM9 is highly expressed in renal cell cancer and is associated with tumour progression. BMC Cancer 2008, 8:179.
30. Barberis M., Pellegrini C., Cannone M., Arizzi C., Coggi G., Bosari S. Quantitative PCR and HER2 testing in breast cancer: a technical and cost-effectiveness analysis. Am J Clin Pathol 2008, 129:563-570.
31. Bartkova J., Lukas J., Strauss M., Bartek J. Cell cycle-related variation and tissue-restricted expression of human cyclin D1 protein. J Pathol 1994, 172:237-245.
32. Quintanilla-Martinez L., Slotta-Huspenina J., Koch I., et al. Differential diagnosis of cyclin D2+ mantle cell lymphoma based on fluorescence in situ hybridization and quantitative real-time-PCR. Haematologica 2009, 94:1488-1492.
33. Wlodarska I., Dierickx D., Vanhentenrijk V., et al. Translocations targeting CCND2, CCND3, and MYCN do occur in t(11;14)-negative mantle cell lymphomas. Blood 2008, 111:5683-5690.
34. Hirose M., Shimizu E., Nakanishi H., Shinohara A., Sone S., Kuroda Y. Expression level of G1 cyclins and cell proliferation in human cultured leukemia/lymphoma cell lines. Int J Oncol 1998, 12:841-846.
35. Motokura T., Bloom T., Kim H.G., et al. A novel cyclin encoded by a bcl1-linked candidate oncogene. Nature 1991, 350:512-515.